Elizabeth Kutter
#111,109
Most Influential Person Now
Researcher ORCID ID = 0000-0002-2775-684X
Elizabeth Kutter's AcademicInfluence.com Rankings
Elizabeth Kutterbiology Degrees
Biology
#15174
World Rank
#19098
Historical Rank
Virology
#391
World Rank
#400
Historical Rank
Microbiology
#1011
World Rank
#1125
Historical Rank
Neuroscience
#2721
World Rank
#2792
Historical Rank
Download Badge
Biology
Elizabeth Kutter's Degrees
- PhD Microbiology University of California, Berkeley
- Masters Microbiology University of California, Berkeley
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Elizabeth Kutter Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dr. Elizabeth Kutter is a phage biologist based at the Evergreen State College in Olympia, Washington, USA, where she is a Professor Emeritus. She led the T4 Genome Sequencing project, and organized the biennial Evergreen International Phage Biology meetings that draw hundreds of phage researchers from all over the world.
Elizabeth Kutter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Phage treatment of human infections (2011) (732)
- Tackling antibiotic resistance (2011) (653)
- Bacteriophage T4 Genome (2003) (650)
- Phage therapy in clinical practice: treatment of human infections. (2010) (568)
- Bacteriophages: Biology and Applications (2007) (549)
- Phage host range and efficiency of plating. (2009) (315)
- In Vitro and In Vivo Bacteriolytic Activities of Escherichia coli Phages: Implications for Phage Therapy (2004) (222)
- The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? (2011) (221)
- Bacteriophage Therapy in Humans (2004) (199)
- Quality and Safety Requirements for Sustainable Phage Therapy Products (2015) (166)
- Basic Phage Biology (2004) (158)
- Bacteriophage isolated from feedlot cattle can reduce Escherichia coli O157:H7 populations in ruminant gastrointestinal tracts. (2008) (152)
- Isolation and Characterization of a New T-Even Bacteriophage, CEV1, and Determination of Its Potential To Reduce Escherichia coli O157:H7 Levels in Sheep (2006) (147)
- Degradation of cytosin-containing bacterial and bacteriophage DNA after infection of Escherichia coli B with bacteriophage T4D wild type and with mutants defective in genes 46, 47 and 56. (1968) (143)
- Evaluation of lytic activity of staphylococcal bacteriophage Sb‐1 against freshly isolated clinical pathogens (2011) (126)
- Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. (2016) (116)
- Bacteriophage T4 Infection of Stationary Phase E. coli: Life after Log from a Phage Perspective (2016) (105)
- Re-establishing a place for phage therapy in western medicine. (2015) (99)
- Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections (2016) (97)
- Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the “N4-like viruses” (2010) (87)
- The roles of the bacteriophage T4 r genes in lysis inhibition and fine-structure genetics: a new perspective. (1998) (84)
- Fecal prevalence of Escherichia coli O157, Salmonella, Listeria, and Bacteriophage Infecting E. coli O157:H7 in feedlot cattle in the Southern Plains region of the United States. (2006) (81)
- Isolation of Escherichia coli Bacteriophages from the Stool of Pediatric Diarrhea Patients in Bangladesh (2004) (78)
- Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157 (2011) (77)
- A suggested new bacteriophage genus: “Viunalikevirus” (2012) (74)
- Bacteriophages: A Therapy Concept against Multi-Drug–Resistant Bacteria (2018) (73)
- Effects of storage conditions on the stability of spray dried, inhalable bacteriophage powders. (2017) (73)
- The Susceptibility of Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients to Bacteriophages (2013) (71)
- A gene of bacteriophage T4 whose product prevents true late transcription on cytosine-containing T4 DNA. (1976) (69)
- Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection (2017) (69)
- Compassionate Use of Bacteriophage Therapy for Foot Ulcer Treatment as an Effective Step for Moving Toward Clinical Trials. (2018) (66)
- Bacteriophage treatment of intransigent diabetic toe ulcers: a case series. (2016) (58)
- A non-essential domain of Escherichia coli RNA polymerase required for the action of the termination factor Alc. (1994) (58)
- Characterization of a ViI-like Phage Specific to Escherichia coli O157:H7 (2011) (58)
- The production of undegraded cytosine-containing DNA by bacteriophage T4 in the absence of dCTPase and endonucleases II and IV, and its effects on T4-directed protein synthesis. (1975) (55)
- A restriction map of the bacteriophage T4 genome (2004) (54)
- Effects of the antibiotic ionophores monensin, lasalocid, laidlomycin propionate and bambermycin on Salmonella and E. coli O157:H7 in vitro. (2003) (54)
- Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa (2018) (54)
- Resolving Digital Staphylococcal Osteomyelitis Using Bacteriophage—A Case Report (2018) (54)
- Regulation of a bacteriophage T4 late gene, soc, which maps in an early region. (1984) (53)
- Bacteriophage T4 Alc protein: A transcription termination factor sensing local modification of DNA (1993) (50)
- Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients (2019) (49)
- Effect of storage temperature on the stability of spray dried bacteriophage powders (2018) (49)
- Evolution of T4-related phages (2005) (48)
- Molecular mechanisms of phage infection (2005) (48)
- Biological Effects of Substituting Cytosine for 5-Hydroxymethylcytosine in the Deoxyribonucleic Acid of Bacteriophage T4 (1969) (46)
- Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model Assays (2015) (44)
- Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation (2017) (43)
- Structure and Function of the Branched Receptor-Binding Complex of Bacteriophage CBA120. (2019) (42)
- From Host to Phage Metabolism: Hot Tales of Phage T4’s Takeover of E. coli (2018) (41)
- Prevalence of Escherichia coli O157 and O157:H7‐infecting bacteriophages in feedlot cattle feces (2007) (41)
- Comparison of synonymous codon distribution patterns of bacteriophage and host genomes. (1998) (40)
- Inhalable combination powder formulations of phage and ciprofloxacin for P. aeruginosa respiratory infections. (2019) (37)
- Storage stability of inhalable phage powders containing lactose at ambient conditions (2019) (36)
- What Can We Learn from a Metagenomic Analysis of a Georgian Bacteriophage Cocktail? (2015) (33)
- Inhalable bacteriophage powders: Glass transition temperature and bioactivity stabilization (2020) (29)
- Nebulization effects on structural stability of bacteriophage PEV 44 (2018) (29)
- Jet nebulization of bacteriophages with different tail morphologies – Structural effects (2019) (25)
- Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model. (2020) (25)
- Development of a broad-spectrum Salmonella phage cocktail containing Viunalike and Jerseylike viruses isolated from Thailand. (2020) (24)
- Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: A Proof-of-Concept study. (2020) (24)
- Microfluidic‐assisted bacteriophage encapsulation into liposomes (2018) (22)
- Bacteriophage T4 alc gene product: general inhibitor of transcription from cytosine-containing DNA (1981) (22)
- Occurrence of Salmonella-specific bacteriophages in swine feces collected from commercial farms. (2010) (22)
- Current Updates from the Long-Standing Phage Research Centers in Georgia, Poland, and Russia (2021) (22)
- Phage Cocktail Powder for Pseudomonas aeruginosa Respiratory Infections. (2021) (22)
- Bacteriophages: it's a medicine, Jim, but not as we know it. (2020) (22)
- Bacteriophage: Therapeutic Uses (2014) (21)
- Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice (2020) (21)
- Approaches to Controlling Escherichia coli O157:H7, a Foodborne Pathogen and an Emerging Environmental Hazard (2004) (21)
- Genomics and Evolution of Tailed Phages (2004) (20)
- Inhibition of transcription of cytosine-containing DNA in vitro by the alc gene product of bacteriophage T4 (1990) (18)
- Synthesis of T4 DNA and bacteriophage in the absence of dCMP hydroxymethylase (1978) (18)
- Identification and characterization of the alc gene product of bacteriophage T4. (1984) (17)
- Anti-Pseudomonal activity of phage PEV20 in a dry powder formulation — A proof-of-principle study in a murine lung infection model (2017) (14)
- Efficacy assessment of PEV2 phage on Galleria mellonella larvae infected with a Pseudomonas aeruginosa dog otitis isolate. (2021) (13)
- Bacteriophage Therapy: Past and Present (2009) (13)
- Effects on host genome and structure (1994) (12)
- The genetic basis of phage susceptibility, cross-resistance and host-range in Salmonella (2020) (12)
- Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infections. (2020) (11)
- The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice. (2022) (10)
- Systematic Discovery of Salmonella Phage-Host Interactions via High-Throughput Genome-Wide Screens (2020) (9)
- Bacteriophage Therapy as a Potential Management Option for Surgical Wound Infections. (2020) (8)
- Introduction to Bacteriophages (2015) (8)
- Identification of bacteriophage T4 prereplicative proteins on two-dimensional polyacrylamide gels (1994) (7)
- Phage Therapy Bacteriophages as Natural, Self-Replicating Antimicrobials (2015) (6)
- Hydrogel formulations containing non-ionic polymers for topical delivery of bacteriophages. (2021) (5)
- Phage Therapy (2020) (4)
- T4-like viruses (2002) (3)
- Anna S. Tikhonenko (2013) (3)
- Anecdotal, historical and critical commentaries on genetics. Gisela Mosig. (2004) (3)
- Phage Therapy: Bacteriophages as Natural, Self-Replicating Antimicrobials (2)
- Isolation of Salmonella spp. and bacteriophage active against Salmonella spp. from commercial swine (2007) (2)
- Beyond interoperability-tracking and managing the results of computational applications (1997) (1)
- An Interview with Elizabeth Kutter, PhD: The First Lady of Phage Research, Part 1. (2020) (0)
- Editorial: Pharmacological and Immunological Action of Bacteriophages: Focus on Phage Therapy (2022) (0)
- A suggested new bacteriophage genus: “Viunalikevirus” (2012) (0)
- An Overview of Current Phage Therapy: Challenges for Implementation (2020) (0)
- , Diarrhea Patients in Bangladesh Bacteriophages from the Stool of Pediatric Escherichia coli Isolation of (2004) (0)
- Host-Lethal Gene (2001) (0)
- Production of Inhalable Bacteriophage Dry Powders (2017) (0)
- Universal Genetic Code (2001) (0)
- Overview: A System for Tracking and Managing the Results from Sequence Comparison Programs (1999) (0)
- Preparation of liposome-encapsulated bacteriophage PEV2 formulation (2017) (0)
- Quality and Safety Requirements for Sustainable Phage Therapy Products (2015) (0)
- Production of Inhalation Phage Powders Using Spray Freeze Drying and Spray Drying Techniques for Treatment of Respiratory Infections (2016) (0)
- Topical liquid formulation of bacteriophages for metered-dose spray delivery. (2022) (0)
- Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients (2019) (0)
- Pharmacokinetics and pharmacodynamics of inhaled antipseudomonal bacteriophage therapy in mice (2020) (0)
- Integrated sequence database of bacteriophage T4 (1993) (0)
- Early Genes (in Phage Genomes) (2001) (0)
This paper list is powered by the following services:
Other Resources About Elizabeth Kutter
What Schools Are Affiliated With Elizabeth Kutter?
Elizabeth Kutter is affiliated with the following schools:
